← Back to Search

Behavioral Intervention

Group Exercise Program for Prostate Cancer Survivors and Caregivers

N/A

Recruiting

Led By Meghan B Skiba, PhD, MS, MPH, RDN

Research Sponsored by University of Arizona

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Ability to ambulate (with or without assistive devices)

Histologically confirmed prostate cancer diagnosis (self-report)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up hr-qol will be measured over a 6 month period. it will be measured at baseline, 3 months, and 6 months.

Awards & highlights

Study Summary

This trial explores how an adapted group exercise program can improve physical/mental health of prostate cancer survivors & their informal caregivers. Participants will take part in supervised classes via videoconferencing for 3-months, with 3-months follow-up.

Who is the study for?

This trial is for Hispanic individuals who have completed primary treatment for prostate cancer at least 6 weeks ago and their caregivers, who can be anyone providing unpaid support. Participants must be over 18, understand English or Spanish, able to exercise and willing to attend online classes and complete surveys.Check my eligibility

What is being tested?

The study tests the 'Exercising Together' program—a partnered resistance training routine conducted via videoconferencing software. It aims to improve physical and mental health of prostate cancer survivors and their caregivers over a period of 3 months with a follow-up after another 3 months.See study design

What are the potential side effects?

Since this intervention involves exercise, potential side effects may include muscle soreness, fatigue, or injury related to physical activity. However, specific side effects will depend on individual health conditions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I can walk by myself or with help from devices.

Select...

I have been diagnosed with prostate cancer.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ hr-qol will be measured over a 6 month period. it will be measured at baseline, 3 months, and 6 months.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~hr-qol will be measured over a 6 month period. it will be measured at baseline, 3 months, and 6 months.

This trial's timeline: 3 weeks for screening, Varies for treatment, and hr-qol will be measured over a 6 month period. it will be measured at baseline, 3 months, and 6 months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability measured by adherence to intervention

Appropriateness measured by retention rate

Feasibility measured by enrollment rate

+1 more

Secondary outcome measures

Health-Related Quality of Life (HR-QOL) for the caregiver

Health-Related Quality of Life (HR-QOL) for the survivor

Objective Physical Function

+2 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Exercising TogetherExperimental Treatment1 Intervention

Dyads perform partnered exercise over 1 hour, 3 days per week in a supervised, group setting remotely for 3 months.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of ArizonaLead Sponsor

515 Previous Clinical Trials

148,674 Total Patients Enrolled

9 Trials studying Prostate Cancer

1,294 Patients Enrolled for Prostate Cancer

Meghan B Skiba, PhD, MS, MPH, RDNPrincipal InvestigatorUniversity of Arizona College of Nursing Biobehavioral Health Science Division

1 Previous Clinical Trials

42 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the criteria for this test include individuals beyond 30 years of age?

"Patients aged 18 and above, but under the age of 99 are currently being invited to join this clinical trial."

Answered by AI

Is enrollment open for this experiment?

"In accordance with clinicaltrials.gov, this medical trial is no longer recruiting patients. It was first advertised on September 30th 2023 and the last update came a few days later on September 20th 2023. Although there are not any more slots open for this study, 4016 other trials across various conditions are still actively enrolling volunteers."

Answered by AI

What is the intended outcome of this clinical trial?

"This research is scheduled to be conducted over a 3-month period with the primary goal of determining appropriateness. Additionally, health related quality of life (HR-QOL) for both caregivers and survivors will be evaluated using 27 item Functional Assessment of Cancer Therapy - General (FACT-G) or 39 item FACT-P subscales respectively. Furthermore, relationship health will also be assessed through six items in the Relationship Quality Index (RQI), which are five point likert scales where higher scores denote greater HR-QOL."

Answered by AI